Easing Access to Lung Cancer Screening: The Potential Impact of Blood Tests

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-22-2026 7PM EDT 4 min · 22 Sep 2026 · NPR News Now

Garry and Tim - Full Show - Wednesday September 23 (23.09.26) 1h 53m · 22 Sep 2026 · SEN Breakfast

H4 N2K, Shehan Jeyarajah, The Kicker 45 min · 22 Sep 2026 · The Program

US-Iran Talks on Sidelines of UN Summit, Chipmakers Rally, More 7 min · 22 Sep 2026 · Bloomberg News Now

7PM ET 09/22/2026 Newscast 3 min · 22 Sep 2026 · Fox News Hourly Update

Dentists Are Making Millions From This Lie - Dr. Ellie Phillips EXPOSES the dental industry 1h 5m · 22 Sep 2026 · Redacted News

Report any issue

Source

Recorded11 Jan 2024

Publisherfeeds.buzzsprout.com

Handlerec:1648202

Show notes

Peter Mazzone, MD, MPH, pulmonologist and Section Leader for Thoracic Oncology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the development of blood tests to screen for lung cancer. Listen as Dr. Mazzone explains the intricacies of DNA analysis within these tests, offering insights into their potential to detect lung cancer and alleviate barriers to screenings.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in